Logo image of DRX.CA

ADF GROUP INC (DRX.CA) Stock Fundamental Analysis

TSX:DRX - Toronto Stock Exchange - CA00089N1033 - Common Stock - Currency: CAD

7.78  -0.32 (-3.95%)

Fundamental Rating

8

Taking everything into account, DRX scores 8 out of 10 in our fundamental rating. DRX was compared to 820 industry peers in the Metals & Mining industry. Both the health and profitability get an excellent rating, making DRX a very profitable company, without any liquidiy or solvency issues. DRX may be a bit undervalued, certainly considering the very reasonable score on growth This makes DRX very considerable for value and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year DRX was profitable.
DRX had a positive operating cash flow in the past year.
DRX had positive earnings in 4 of the past 5 years.
In multiple years DRX reported negative operating cash flow during the last 5 years.
DRX.CA Yearly Net Income VS EBIT VS OCF VS FCFDRX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

DRX has a Return On Assets of 18.92%. This is amongst the best in the industry. DRX outperforms 97.03% of its industry peers.
DRX's Return On Equity of 35.77% is amongst the best of the industry. DRX outperforms 97.57% of its industry peers.
DRX has a better Return On Invested Capital (31.21%) than 99.59% of its industry peers.
DRX had an Average Return On Invested Capital over the past 3 years of 11.99%. This is in line with the industry average of 11.94%.
The 3 year average ROIC (11.99%) for DRX is below the current ROIC(31.21%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 18.92%
ROE 35.77%
ROIC 31.21%
ROA(3y)7.23%
ROA(5y)4.83%
ROE(3y)14.66%
ROE(5y)9.74%
ROIC(3y)11.99%
ROIC(5y)8.77%
DRX.CA Yearly ROA, ROE, ROICDRX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

The Profit Margin of DRX (16.60%) is better than 95.14% of its industry peers.
In the last couple of years the Profit Margin of DRX has grown nicely.
The Operating Margin of DRX (23.25%) is better than 94.19% of its industry peers.
DRX's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 29.91%, DRX belongs to the top of the industry, outperforming 91.35% of the companies in the same industry.
In the last couple of years the Gross Margin of DRX has grown nicely.
Industry RankSector Rank
OM 23.25%
PM (TTM) 16.6%
GM 29.91%
OM growth 3Y31.87%
OM growth 5YN/A
PM growth 3Y41.66%
PM growth 5YN/A
GM growth 3Y13.22%
GM growth 5Y25.39%
DRX.CA Yearly Profit, Operating, Gross MarginsDRX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

8

2. Health

2.1 Basic Checks

DRX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for DRX remains at a similar level compared to 1 year ago.
The number of shares outstanding for DRX remains at a similar level compared to 5 years ago.
Compared to 1 year ago, DRX has an improved debt to assets ratio.
DRX.CA Yearly Shares OutstandingDRX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DRX.CA Yearly Total Debt VS Total AssetsDRX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

DRX has an Altman-Z score of 3.35. This indicates that DRX is financially healthy and has little risk of bankruptcy at the moment.
DRX's Altman-Z score of 3.35 is fine compared to the rest of the industry. DRX outperforms 60.68% of its industry peers.
DRX has a debt to FCF ratio of 0.61. This is a very positive value and a sign of high solvency as it would only need 0.61 years to pay back of all of its debts.
DRX's Debt to FCF ratio of 0.61 is amongst the best of the industry. DRX outperforms 94.86% of its industry peers.
DRX has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
DRX has a Debt to Equity ratio of 0.26. This is in the lower half of the industry: DRX underperforms 74.59% of its industry peers.
Although DRX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 0.61
Altman-Z 3.35
ROIC/WACC3.23
WACC9.66%
DRX.CA Yearly LT Debt VS Equity VS FCFDRX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 2.22 indicates that DRX has no problem at all paying its short term obligations.
With a Current ratio value of 2.22, DRX perfoms like the industry average, outperforming 54.32% of the companies in the same industry.
A Quick Ratio of 2.08 indicates that DRX has no problem at all paying its short term obligations.
With a Quick ratio value of 2.08, DRX perfoms like the industry average, outperforming 54.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.22
Quick Ratio 2.08
DRX.CA Yearly Current Assets VS Current LiabilitesDRX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 105.30% over the past year.
Measured over the past years, DRX shows a very strong growth in Earnings Per Share. The EPS has been growing by 76.40% on average per year.
Looking at the last year, DRX shows a quite strong growth in Revenue. The Revenue has grown by 19.21% in the last year.
The Revenue has been growing by 19.63% on average over the past years. This is quite good.
EPS 1Y (TTM)105.3%
EPS 3Y76.4%
EPS 5YN/A
EPS Q2Q%61.76%
Revenue 1Y (TTM)19.21%
Revenue growth 3Y24.24%
Revenue growth 5Y19.63%
Sales Q2Q%-2.67%

3.2 Future

DRX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.93% yearly.
DRX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.15% yearly.
EPS Next Y86.24%
EPS Next 2Y29.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.04%
Revenue Next 2Y4.15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DRX.CA Yearly Revenue VS EstimatesDRX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
DRX.CA Yearly EPS VS EstimatesDRX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5 2

10

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 4.21, the valuation of DRX can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of DRX indicates a rather cheap valuation: DRX is cheaper than 97.16% of the companies listed in the same industry.
DRX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.63.
With a Price/Forward Earnings ratio of 4.19, the valuation of DRX can be described as very cheap.
DRX's Price/Forward Earnings ratio is rather cheap when compared to the industry. DRX is cheaper than 96.89% of the companies in the same industry.
DRX is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.21
Fwd PE 4.19
DRX.CA Price Earnings VS Forward Price EarningsDRX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DRX indicates a rather cheap valuation: DRX is cheaper than 99.73% of the companies listed in the same industry.
99.19% of the companies in the same industry are more expensive than DRX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.74
EV/EBITDA 1.3
DRX.CA Per share dataDRX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of DRX may justify a higher PE ratio.
A more expensive valuation may be justified as DRX's earnings are expected to grow with 29.93% in the coming years.
PEG (NY)0.05
PEG (5Y)N/A
EPS Next 2Y29.93%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

DRX has a yearly dividend return of 0.49%, which is pretty low.
Compared to an average industry Dividend Yield of 7.55, DRX pays a better dividend. On top of this DRX pays more dividend than 94.32% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, DRX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.49%

5.2 History

The dividend of DRX has a limited annual growth rate of 0.10%.
DRX has been paying a dividend for at least 10 years, so it has a reliable track record.
DRX has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.1%
Div Incr Years1
Div Non Decr Years13
DRX.CA Yearly Dividends per shareDRX.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.01 0.01 0.02 0.02 0.03

5.3 Sustainability

1.59% of the earnings are spent on dividend by DRX. This is a low number and sustainable payout ratio.
The dividend of DRX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP1.59%
EPS Next 2Y29.93%
EPS Next 3YN/A
DRX.CA Yearly Income VS Free CF VS DividendDRX.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M
DRX.CA Dividend Payout.DRX.CA Dividend Payout, showing the Payout Ratio.DRX.CA Dividend Payout.PayoutRetained Earnings

ADF GROUP INC

TSX:DRX (2/21/2025, 7:00:00 PM)

7.78

-0.32 (-3.95%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)12-12 2024-12-12/bmo
Earnings (Next)04-09 2025-04-09
Inst Owners5.76%
Inst Owner ChangeN/A
Ins Owners3.46%
Ins Owner ChangeN/A
Market Cap132.88M
Analysts84
Price Target23.46 (201.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.49%
Yearly Dividend0.02
Dividend Growth(5Y)0.1%
DP1.59%
Div Incr Years1
Div Non Decr Years13
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.55%
Min EPS beat(2)29.47%
Max EPS beat(2)39.63%
EPS beat(4)4
Avg EPS beat(4)31.96%
Min EPS beat(4)21.86%
Max EPS beat(4)39.63%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-10.74%
Min Revenue beat(2)-19.94%
Max Revenue beat(2)-1.54%
Revenue beat(4)2
Avg Revenue beat(4)2.51%
Min Revenue beat(4)-19.94%
Max Revenue beat(4)18.02%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)13.16%
EPS NQ rev (3m)34.38%
EPS NY rev (1m)14.04%
EPS NY rev (3m)13.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.6%
Valuation
Industry RankSector Rank
PE 4.21
Fwd PE 4.19
P/S 0.38
P/FCF 1.74
P/OCF 1.56
P/B 0.82
P/tB 0.84
EV/EBITDA 1.3
EPS(TTM)1.85
EY23.78%
EPS(NY)1.86
Fwd EY23.89%
FCF(TTM)4.48
FCFY57.56%
OCF(TTM)5
OCFY64.28%
SpS20.53
BVpS9.53
TBVpS9.29
PEG (NY)0.05
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 18.92%
ROE 35.77%
ROCE 36.79%
ROIC 31.21%
ROICexc 44.31%
ROICexgc 45.51%
OM 23.25%
PM (TTM) 16.6%
GM 29.91%
FCFM 21.81%
ROA(3y)7.23%
ROA(5y)4.83%
ROE(3y)14.66%
ROE(5y)9.74%
ROIC(3y)11.99%
ROIC(5y)8.77%
ROICexc(3y)15.29%
ROICexc(5y)11%
ROICexgc(3y)15.68%
ROICexgc(5y)11.28%
ROCE(3y)14.13%
ROCE(5y)10.34%
ROICexcg growth 3Y47.4%
ROICexcg growth 5YN/A
ROICexc growth 3Y47.59%
ROICexc growth 5YN/A
OM growth 3Y31.87%
OM growth 5YN/A
PM growth 3Y41.66%
PM growth 5YN/A
GM growth 3Y13.22%
GM growth 5Y25.39%
F-Score8
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 0.61
Debt/EBITDA 0.48
Cap/Depr 148.52%
Cap/Sales 2.55%
Interest Coverage 27.41
Cash Conversion 97.57%
Profit Quality 131.4%
Current Ratio 2.22
Quick Ratio 2.08
Altman-Z 3.35
F-Score8
WACC9.66%
ROIC/WACC3.23
Cap/Depr(3y)258.98%
Cap/Depr(5y)169.73%
Cap/Sales(3y)4.89%
Cap/Sales(5y)3.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105.3%
EPS 3Y76.4%
EPS 5YN/A
EPS Q2Q%61.76%
EPS Next Y86.24%
EPS Next 2Y29.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.21%
Revenue growth 3Y24.24%
Revenue growth 5Y19.63%
Sales Q2Q%-2.67%
Revenue Next Year7.04%
Revenue Next 2Y4.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y101.39%
EBIT growth 3Y63.84%
EBIT growth 5YN/A
EBIT Next Year168.03%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y426.95%
FCF growth 3Y38.23%
FCF growth 5Y55.22%
OCF growth 1Y1607.23%
OCF growth 3Y39.24%
OCF growth 5Y46.14%